← back to search

Xinran Wang

Chongqing University of Posts and Telecommunications · CN
Area of research
Oncology · Signal Processing
Research interest
Research interests include Advanced Malware Detection Techniques, Cancer Immunotherapy and Biomarkers, AI in cancer detection, and Network Security and Intrusion Detection.
h-index
18
citations
1,582
works
54
NIH funding
primary concept
email

Recent publications

A T2-weighted MRI grading system for preoperative prediction of visceral pleural invasion in small non-small cell lung cancers
Frontiers in Oncology 2025cited by 0position: middledoi
Artificial intelligence enhances whole‐slide interpretation of PD‐L1 CPS in triple‐negative breast cancer: A multi‐institutional ring study
Histopathology 2024cited by 12position: middledoi
Concordance of assessments of four PD-L1 immunohistochemical assays in esophageal squamous cell carcinoma (ESCC)
Journal of Cancer Research and Clinical Oncology 2024cited by 11position: firstdoi
Abstract PO5-07-02: AI-assisted interpretation of PD-L1 CPS improves the precision medicine in Triple-negative breast cancer
Cancer Research 2024cited by 1position: middledoi
The Role of Artificial Intelligence in Accurate Interpretation of HER2 Immunohistochemical Scores 0 and 1+ in Breast Cancer
Modern Pathology 2023cited by 97position: middledoi
The devil is in the details: a small-lesion sensitive weakly supervised learning framework for prostate cancer detection and grading
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2023cited by 16position: middledoi
Tumor infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in relation to pathological complete remission to neoadjuvant therapy and prognosis in triple negative breast cancer
Pathology - Research and Practice 2023cited by 11position: middledoi
Effect of storage time of paraffin sections on the expression of PD-L1 (SP142) in invasive breast cancer
Diagnostic Pathology 2023cited by 10position: middledoi
RT-qPCR is helpful to distinguish the clinicopathological features of HER2 immunohistochemistry 0 and 1 +
Pathology - Research and Practice 2023cited by 10position: middledoi
Clinicopathological features and prognostic analysis of HER2 low and fibrotic focus in HER2-negative breast cancer
Breast Cancer Research and Treatment 2023cited by 1position: middledoi
High Dynamic Range Dual-Modal White Light Imaging Improves the Accuracy of Tumor Bed Sampling After Neoadjuvant Therapy for Breast Cancer
American Journal of Clinical Pathology 2023cited by 1position: middledoi
The new idea of cancer immunotherapy: the expression of PD-L1 may reveal the immunological mechanism of resistance of EGFR-TKIs
Research Square 2023cited by 0position: middledoi
Automatic diagnosis and grading of Prostate Cancer with weakly supervised learning on whole slide images
Computers in Biology and Medicine 2022cited by 58position: middledoi
The efficacy of additional surgical resection after endoscopic resection in pT1b esophageal squamous cell carcinoma: A multi-institutional retrospective study in China
Surgical Endoscopy 2022cited by 5position: middledoi
The role of artificial intelligence in accurate interpretation of HER2 IHC 0 and 1+ in breast cancers
Research Square 2022cited by 1position: middledoi
High dynamic range dual-modal white light imaging system improves the accuracy of tumor bed sampling after neoadjuvant therapy for breast cancer
Research Square 2022cited by 0position: lastdoi
Can AI-assisted microscope facilitate breast HER2 interpretation? A multi-institutional ring study
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2021cited by 55position: middledoi
How can artificial intelligence models assist PD-L1 expression scoring in breast cancer: results of multi-institutional ring studies
npj Breast Cancer 2021cited by 41position: firstdoi
Improving Ki67 assessment concordance by the use of an artificial intelligence‐empowered microscope: a multi‐institutional ring study
Histopathology 2021cited by 24position: middledoi
The efficacy of current-used risk factors for metastasis and the effectiveness of additional surgical resection in pT1b esophageal squamous cell carcinoma after endoscopic resection: A multi-institutional retrospective study in China
Research Square 2021cited by 0position: middledoi
Prognostic implications of stromal tumor-infiltrating lymphocytes and programmed death ligand 1 expression in HER2-positive invasive breast cancer
Research Square (Research Square) 2020cited by 1position: firstdoi
Intratumoral heterogeneity of esophageal squamous cell carcinoma and its clinical significance
Pathology - Research and Practice 2018cited by 4position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Yueping Liu · Hebei Medical University21 papers (2018–2024)Lijing Cai · Hebei Medical University10 papers (2021–2024)Xiao Han · The First Affiliated Hospital, Sun Yat-sen University8 papers (2021–2024)Jinze Li · Hebei Medical University7 papers (2022–2024)Zhanli Jia · Hebei Medical University7 papers (2021–2024)Jianhua Yao · Trine University5 papers (2021–2023)Si Wu · Hebei Medical University5 papers (2022–2023)Jiankun He · Hebei Medical University5 papers (2021–2024)Jun Zhang · University of Science and Technology of China5 papers (2021–2024)Ying Jia · Ministry of Agriculture and Rural Affairs4 papers (2018–2024) · 3 papers (2022–2024) · 3 papers (2021–2021)Mengxue Han · Hebei Medical University3 papers (2022–2024)Dandan Han · University of Science and Technology of China3 papers (2021–2023) · 3 papers (2021–2021)Junzhou Huang · Xiamen University3 papers (2021–2021)Shuyao Niu · Hebei Medical University3 papers (2021–2024)Jiuyan Shang · Hebei Medical University3 papers (2021–2023)Yao Liu · Hebei Medical University2 papers (2018–2022) · 2 papers (2021–2022)